SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-19-007856
Filing Date
2019-04-29
Accepted
2019-04-29 16:42:52
Documents
5
Period of Report
2019-06-06
Effectiveness Date
2019-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A formdef14a.htm DEF 14A 431435
2 image0.jpg GRAPHIC 6356
3 image00001.jpg GRAPHIC 689
4 image00004.jpg GRAPHIC 51327
5 image00005.jpg GRAPHIC 58210
  Complete submission text file 0001140361-19-007856.txt   593586
Mailing Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Filer) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-34079 | Film No.: 19776532
SIC: 2834 Pharmaceutical Preparations